Review
Published on 18 Dec 2025
Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug development
in Experimental Pharmacology and Drug Discovery
- 1,299 views
- 1 citation
Review
Published on 18 Dec 2025
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 18 Dec 2025
in Drugs Outcomes Research and Policies
Original Research
Published on 18 Dec 2025
in Pharmacology of Infectious Diseases
Editorial
Published on 18 Dec 2025
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 18 Dec 2025
in Predictive Toxicology
Original Research
Published on 18 Dec 2025
in Renal Pharmacology
Original Research
Published on 18 Dec 2025
in Ethnopharmacology
Systematic Review
Published on 18 Dec 2025
in Ethnopharmacology
Original Research
Published on 18 Dec 2025
in Drug Metabolism and Transport
Policy and Practice Reviews
Published on 18 Dec 2025
in Pharmacology of Infectious Diseases
Original Research
Published on 18 Dec 2025
in Drug Metabolism and Transport
Mini Review
Published on 18 Dec 2025
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 18 Dec 2025
in Renal Pharmacology
Original Research
Published on 18 Dec 2025
in Inflammation Pharmacology
Original Research
Published on 18 Dec 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 18 Dec 2025
in Pharmacology of Anti-Cancer Drugs
Opinion
Published on 18 Dec 2025
in Drug Metabolism and Transport
Clinical Trial
Published on 18 Dec 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 18 Dec 2025
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 18 Dec 2025
in Ethnopharmacology
Review
Published on 18 Dec 2025
in Renal Pharmacology
Original Research
Published on 18 Dec 2025
in Ethnopharmacology
Original Research
Accepted on 17 Dec 2025
in Ethnopharmacology
Systematic Review
Accepted on 17 Dec 2025
in Gastrointestinal and Hepatic Pharmacology